Bono-backed Nuritas raises $42 million
In Ireland, Nuritas, an AI-powered peptide discovery firm, has successfully closed an oversubscribed $42 million Series C funding round. The round was led by...
“Egg-cellent” idea: Onego Bio submits GRAS notification for chicken-free albumen
In the US, Finnish food ingredient company Onego Bio has officially submitted its Generally Recognized as Safe notification to the U.S. Food and Drug...
Faux foie gras firm forms foodie panel
In Paris, cultivated meat startup Gourmey has formed what it claims is the culinary industry’s first-ever advisory board dedicated to cultivated meat.
The panel...
Celleste Bio secures $4.5 million for cell-cultured cocoa
In Israel, cell cultured cocoa startup Celleste Bio has raised $4.5 million in a seed funding round. The funds will boost the company's research...
Aleph Farms files for Cultivated Meat in Thailand
In Israel, Aleph Farms has submitted its first regulatory application for cultivated meat in Thailand. This application, filed in collaboration with Thai Union, aims...
UMAMI Bioworks and Steakholder Foods achieve 3D-printed, cultivated fish fillets
In Singapore, UMAMI Bioworks and Steakholder Foods have successfully demonstrated the feasibility of producing 3D-printed cultivated fish products at scalable volumes. The two-year project...
World Animal Protection launches AI-Powered cultivated meat chatbot
In London, animal advocacy group World Animal Protection has partnered with AI software company PubTrawlr to unveil Cultivator, the first-ever chatbot dedicated to cultivated...
Friends & Family Pet Food taps Novel Farms for cultivated pork
In California, a pet food startup focused on using sustainable proteins has partnered with cellular agriculture firm Novel Farms to source cultivated meat to...
Äio raises €6.1 million to scale sawdust-to-palm oil technology
In Estonia, foodtech startup Äio has closed a €6.1 million ($6.8 million) funding round to build a demonstration-scale, fermentation-based production unit converting crop and...
Helaina Series B nets $45 million for human lactoferrin bioactive
In New York, biotech company Helaina has raised $45 million to develop and scale human equivalent-bioactive proteins produced via precision fermentation.
The Series B funding...